Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A with recombinant human type III collagen for periocular wrinkles
ChiCTR2200055452Phase 4Recruiting
- Sponsor
- Beijing Chuiyangliu Hospital
- Start
- Jan 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of botulinum toxin type A and recombinant human type III collagen, sponsored by Beijing Chuiyangliu Hospital. Primary endpoint: Wrinkle score. Started Jan 2022; status: recruiting.
02
Drugs
botulinum toxin type Arecombinant human type III collagen
Beyond the preview
Go deeper on ChiCTR2200055452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200055452.